Compare GSK Pharma with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA ABBOTT INDIA GSK PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 56.4 48.9 115.5% View Chart
P/BV x 18.7 13.7 136.2% View Chart
Dividend Yield % 1.8 1.7 109.0%  

Financials

 GSK PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    GSK PHARMA
Mar-21
ABBOTT INDIA
Mar-21
GSK PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,80518,569 9.7%   
Low Rs1,15513,970 8.3%   
Sales per share (Unadj.) Rs188.82,028.2 9.3%  
Earnings per share (Unadj.) Rs21.1325.0 6.5%  
Cash flow per share (Unadj.) Rs25.8352.4 7.3%  
Dividends per share (Unadj.) Rs30.00275.00 10.9%  
Avg Dividend yield %2.01.7 119.9%  
Book value per share (Unadj.) Rs88.51,203.7 7.4%  
Shares outstanding (eoy) m169.4121.25 797.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.88.0 97.7%   
Avg P/E ratio x70.050.1 139.8%  
P/CF ratio (eoy) x57.346.2 124.1%  
Price / Book Value ratio x16.713.5 123.7%  
Dividend payout %141.984.6 167.7%   
Avg Mkt Cap Rs m250,695345,717 72.5%   
No. of employees `000NANA-   
Total wages/salary Rs m6,1474,927 124.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,98943,100 74.2%  
Other income Rs m1,106835 132.5%   
Total revenues Rs m33,09443,935 75.3%   
Gross profit Rs m5,2279,189 56.9%  
Depreciation Rs m793581 136.4%   
Interest Rs m35183 19.3%   
Profit before tax Rs m5,5059,260 59.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9242,353 81.8%   
Profit after tax Rs m3,5816,907 51.9%  
Gross profit margin %16.321.3 76.6%  
Effective tax rate %34.925.4 137.5%   
Net profit margin %11.216.0 69.9%  
BALANCE SHEET DATA
Current assets Rs m22,02735,185 62.6%   
Current liabilities Rs m13,32510,309 129.3%   
Net working cap to sales %27.257.7 47.1%  
Current ratio x1.73.4 48.4%  
Inventory Days Days474 1,048.9%  
Debtors Days Days2462 11,610.1%  
Net fixed assets Rs m8,0763,041 265.5%   
Share capital Rs m1,694213 797.2%   
"Free" reserves Rs m13,29725,366 52.4%   
Net worth Rs m14,99125,579 58.6%   
Long term debt Rs m00-   
Total assets Rs m30,10238,226 78.7%  
Interest coverage x156.951.7 303.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.11.1 94.2%   
Return on assets %12.018.5 64.8%  
Return on equity %23.927.0 88.5%  
Return on capital %37.036.9 100.1%  
Exports to sales %00.7 0.0%   
Imports to sales %0.912.3 7.0%   
Exports (fob) Rs mNA295 0.0%   
Imports (cif) Rs m2765,306 5.2%   
Fx inflow Rs m278353 78.7%   
Fx outflow Rs m2765,389 5.1%   
Net fx Rs m2-5,035 -0.0%   
CASH FLOW
From Operations Rs m5,7797,267 79.5%  
From Investments Rs m4,186-718 -582.8%  
From Financial Activity Rs m-6,961-5,818 119.7%  
Net Cashflow Rs m3,004731 410.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 12.8 7.0 183.0%  
FIIs % 2.0 0.2 927.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   123,480 83,236 148.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

SGX Nifty Tanks 294 Points, Maruti Suzuki Quarterly Results, Oyo's Rs 84 bn IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note on Tuesday. Benchmark indices snapped their five-day losing run and ended on a positive note in a highly volatile session.

Related Views on News

GSK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GSK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

ABBOTT INDIA Announces Quarterly Results (1QFY22); Net Profit Up 8.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 8.5% YoY). Sales on the other hand came in at Rs 12 bn (up 14.4% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Jan 27, 2022 09:31 AM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - MEDPLUS HEALTH SERVICES COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS